Adverse reactions to aspartame: Double-blind challenge in patients from a vulnerable population

      This paper is only available as a PDF. To read, Please Download here.


      This study was designed to ascertain whether individuals with mood disorders are particularly vulnerable to adverse effects of aspartame. Although the protocol required the recruitment of 40 patients with unipolar depression and a similar number of individuals without a psychiatric history, the project was halted by the Institutional Review Board after a total of 13 individuals had completed the study because of the severity of reactions within the group of patients with a history of depression.
      In a crossover design, subjects received aspartame 30 mg/kg/day or placebo for 7 days. Despite the small n, there was a significant difference between aspartame and placebo in number and severity of symptoms for patients with a history of depression, whereas for individuals without such a history there was not. We conclude that individuals with mood disorders are particularly sensitive to this artificial sweetener and its use in this population should be discouraged.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Blundell J.E.
        • Hill A.J.
        Paradoxical effects of an intense sweetener (aspartame) on appetite.
        Lancet. 1986; 1: 1092-1093
        • Bradstock M.K.
        • Serdula M.K.
        • Marks J.S.
        • et al.
        Evaluation of reactions to food additives: the aspartame experience.
        Am J Clin Nutr. 1986; 43: 464-469
        • Camfield P.R.
        • Camfield C.S.
        • Dooley J.M.
        • Gordon K.
        • Jollymore S.
        • Weaver D.F.
        Aspartame exacerbates EEG Spikewave discharge in children with generalized absence epilepsy: A double-blind controlled study.
        Neurology. 1992; 42: 1000-1003
        • Council on Scientific Affairs
        Aspartame: review of safety issues.
        JAMA. 1985; 254: 400-402
        • Drake M.E.
        Panic attacks and excessive aspartame ingestion.
        Lancet. 1986; 2: 631
      1. Evaluation of consumer complaints related to aspartame use.
        MMWR. 1984; 33: 605-607
        • Fernstrom J.D.
        • Fernstrom M.H.
        • Massoudi M.S.
        In vivo tyrosine hydroxylation in rat retina: Effect of aspartame ingestion in rats pretreated with p-chlorophenylalanine.
        Am J Clin Nutr. 1991; 53: 923-929
        • Garriga M.M.
        • Berkebile C.
        • Metcalfe D.D.
        A combined single-blind, double-blind, placebo-controlled study to determine the reproducibility of hypersensitivity reactions to aspartame.
        J Allergy Clin Immunol. 1991; 87: 821-827
        • Johns D.R.
        Migraine provoked by aspartame.
        N Eng J Med. 1986; 315: 456
        • Leone A.S.
        • Hunninghake D.B.
        • Bell C.
        • Rassin D.K.
        • Tephly T.R.
        Safety of long term large doses of aspartame.
        Arch Intern Med. 1989; 149: 2318
        • Lipton R.E.
        • Newman L.C.
        • Solomon S.
        Aspartame and headache.
        N Engl J Med. 1988; 318: 1200
        • Roberts H.J.
        Neurological, psychiatric, and behavioral reactions to aspartame in 505 aspartame reactors.
        in: Wurtman R.J. Walker E.R. Dietary Phenylalanine and Brain Function. Birkhauser, Boston1988: 373-376
        • Schiffman S.S.
        • Buckley C.E.
        • Sampson H.A.
        • et al.
        Aspartame and susceptibility to headache.
        N Engl J Med. 1987; 317: 1181-1185
        • Stegink L.D.
        • Filer L.J.
        • Baker G.L.
        Effects of aspartame loading upon plasma and erythrocyte amino acid levels in phenylketonuria heterozygotes and normal adult subject.
        J Nutr. 1979; 109: 708-717
        • Stegink L.D.
        • Filer L.J.
        • Bell E.F.
        • Ziegler E.E.
        • Tephly T.R.
        • Krause L.
        Repeated ingestion of aspartame-sweetened beverages: Further observations in individuals heterozygous for phenylketonuria.
        Metabolism. 1990; 39: 1076-1081
        • Steinmetzer R.V.
        • Kunkle R.S.
        Aspartame and headaches.
        N Engl J Med. 1988; 318: 1201
        • Walton R.G.
        Seizure and mania after high intake of aspartame.
        Psychosomatics. 1986; 27: 218-220
        • Watts R.S.
        Aspartame, headaches and beta blockers.
        Headache. 1991; 31: 181-182
        • Wurtman R.J.
        Aspartame: Possible effects on seizure susceptibility.
        Lancet. 1985; 2: 1060
        • Wurtman R.J.
        Neurochemical changes following high-dose aspartame with dietary carbohydrates.
        N Engl J Med. 1983; 309: 429-430